CWA Asset Management Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$822K Sell
10,500
-6,047
-37% -$412K 0.03% 417
2026
Q1
$1.07M Buy
16,547
+3,072
+23% +$217K 0.04% 368
2025
Q4
$907K Buy
+13,475
New +$906K 0.03% 371

Other funds holding HALO

CWA Asset Management Group's HALO Position: Q2 2026 in Review

CWA Asset Management Group reduced its Halozyme (HALO) stake by 37% in Q2 2026, selling an estimated $412K and leaving 10,500 shares worth $822K. The position accounts for 0.03% of the portfolio, ranked #417.

CWA Asset Management Group first reported a position in HALO in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.07M in Q1 2026. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • CWA Asset Management Group held 10,500 shares of Halozyme worth $822K as of Q2 2026.
  • CWA Asset Management Group sold 6,047 Halozyme shares in Q2 2026, an estimated $412K.
  • Halozyme made up 0.03% of CWA Asset Management Group's portfolio in Q2 2026, its #417 holding.
  • CWA Asset Management Group first reported a position in Halozyme in Q4 2025 and has held it in 3 quarters since.
  • CWA Asset Management Group's Halozyme position peaked at $1.07M in Q1 2026.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.